Inventor

TESCHNER WOLFGANG

AT39 patents

⚠️ This page may combine multiple inventors who share the name “TESCHNER WOLFGANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TESCHNER WOLFGANG

BAXALTA INC

Removal of serine proteases by treatment with finely divided silicon dioxide

Removal of serine proteases by treatment with finely divided silicon dioxide

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural iggs

Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

Fraction I-IV-1 precipitation of immunoglobins from plasma

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs

Removal of serine proteases by treatment with finely divided silicon dioxide

Removal of serine proteases by treatment with finely divided silicon dioxide

Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pH

Method for producing factor H from a plasma precipitation fraction

BAXTER INT

Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

Method to produce an immunoglobulin preparation with improved yield

Removal of serine proteases by treatment with finely divided silicon dioxide

Removal of serine proteases by treatment with finely divided silicon dioxide

Manufacture of factor H (FH) and FH-derivatives from plasma

Manufacture of factor H (FH) and FH-derivatives from plasma

TESCHNER WOLFGANG

Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof

Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

Removal of serine proteases by treatment with finely divided silicon dioxide

Process for producing a plasma protein-containing medicament with reduced concentration of citrate and metals

Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition

TAKEDA PHARMACEUTICALS CO

Method to produce an immunoglobulin preparation with improved yield

Removal of serine proteases by treatment with finely divided silicon dioxide

Method to produce an immunoglobulin preparation with improved yield

Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS

Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

CIT ALCATEL

Arrangement for branching a telecommunications cable containing several stranded elements with optical fibers

Internal line for fastening cables in a waste-water pipe

Method of laying a cable or pipe

Device for fixing a cable in a pipe

BRUCKSCHWAIGER LEOPOLD

Method to produce an immunoglobulin preparation with improved yield

Method to produce an immunoglobulin preparation with improved yield

STILL FA CARL

System to acquire and monitor operating machinery positions for horizontal coke oven batteries

Method and apparatus for determining the covering of a coke wharf with quenched coke

IMMUNO AG

Highly concentrated immunoglobulin preparation and method for its production

BAIRSTOW SHAWN F

Manufacture of factor H (FH) and FH-derivatives from plasma

BUTTERWECK HARALD ARNO

Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pH

ZAYDENBERG ALEXANDER

Purification of butyrylcholinesterase using membrane adsorption